A service of StreetInsider.com

Most Popular

AAPL 196.19
C 3.18
GOOG 536.44
BAC 14.47
RIMM 66.15

Recently Added

TNGN 0.00
SWS 12.17
ATHX 2.88
MED 17.54
DANA 0.20

Gaining Speed

MKSI 18.55
CTGI 0.14
HLXW 1.03
IHAXX 0.00
SWNM 0.00
1.22 +0.02 (1.61%) CYTR

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:1.22 Change:+0.02 (1.61%) Prev Close:1.20 Open: 1.24 Days Range:1.17 – 1.24 52 Week Range: 0.26 - 1.72 Volume:359285 P/E: N/A
EPS:-0.05

Member Comments

No member comments available for CYTR


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 02/09/10

Recent Alert on 01/13/10 at 8:42am
CytRx (CYTR) to Initiate Phase 2 Proof-of-Concept Trial to Evaluate Efficacy/Safety of Bafetinib

CytRx Corporation (NASDAQ: CYTR) today announced plans to initiate a Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib (formerly known as INNO-406) in patients with high-risk B-cell chronic lymphocytic... Read More

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 01/24/10 at 4:36am
Biotech Bulls Becoming Restless
Blog Posts on 01/16/10 at 12:16am
RXi Pharmaceuticals Talks Partnerships
Blog Posts on 12/03/09 at 3:53am
CytRx Corporation: A Solid Rebound Play?
Blog Posts on 11/24/09 at 8:25am
CytRx Corporation: Key Developments Ahead